Sun Pharma to Acquire Checkpoint Therapeutics
LOCUST WALK NEWS Sun Pharma to Acquire Checkpoint Therapeutics Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment […]
News
2025
Uncategorized
Biotalk Episode 24: Asia’s 2024 Year-In-Review
Podcast: Play in new window | Download (Duration: 12:29 — 28.6MB)
Subscribe: Apple Podcasts | Spotify | RSS
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, explores the evolving biotech landscapes in Japan and China,
Uncategorized
Biotalk Episode 23: 2024 Year-In-Review Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 13:46 — 31.5MB)
Subscribe: Apple Podcasts | Spotify | RSS
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Year-In-Review Report: Global Trends in Biopharma
Insight, Locust Walk Insights, Market Trends, Quarterly Reports
2024 Year-In-Review Report: Global Trends in Biopharma Transactions
2024 Year-In-Review Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on